Zevra Therapeutics Inc.

09/06/2024 | Press release | Distributed by Public on 09/06/2024 06:54

Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA® (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.